Investment
Features
FeesSafety
Academy
More
Pluang+

Compare DexCom, Inc. (DXCM) vs Western Union Co (WU) Price & Performance

DexCom, Inc.Trade
Western Union CoTrade

Price performance (Past 24H)

Key statistics

DexCom, Inc. vs Western Union Co — how do they compare? DexCom, Inc. trades at $77.95 (market cap $28.06B), while Western Union Co trades at $8.37 (market cap $2.51B). The key difference: DexCom, Inc. is far larger — about 11.2× Western Union Co's market cap, and Western Union Co pays a 11.69% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals.

DXCMWU
Market Cap
$28.06B$2.51B
Sector
HealthTechnology
52-Week High
$89.53$10.28
52-Week Low
$54.84$7.04
Enterprise Value
$27.03B$2.21B
Dividend Yield
11.69%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

DexCom, Inc.

DXCM trades at $77.31, up 4.3% on the day, with a bullish technical outlook as it approaches resistance near $78. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $0.56 surpassing expectations of $0.47. Revenue growth accelerated to $4.66 billion in 2025, while net income margin expanded to 17.93%. Recent regulatory approvals, including Health Canada authorization for the G7 15-day CGM, support continued international expansion.

The stock offers growth potential with analyst consensus price target of $84.33, though high valuation multiples (P/E 31.21) and competition in the CGM market present risks. Expansion into non-insulin Type 2 diabetes and pediatric markets could drive future revenue, but commercial uptake remains unproven. Institutional sentiment remains strongly bullish with 80% buy ratings.

Western Union Co

Western Union (WU) trades at $8.275, up 5.01% in the last session, with a bullish technical signal from moving averages. The stock shows strong profitability with a 10.88% net income margin and 47.66% ROE, though recent Q1 2026 earnings missed expectations. Valuation ratios appear attractive with a P/E of 5.91 and P/S of 0.64. Recent developments include a partnership with Total Wireless for fee-free money transfers and progress on the Intermex acquisition, enhancing digital reach.

Outlook is mixed: low valuations and dividend yield near 5.8% offer value, but declining revenue from $4.5B in 2022 to $4.0B projected for 2026 poses growth concerns. Risks include high debt levels and competitive pressures. Analysts are cautious with a consensus hold rating and $7.50 price target below the current price, indicating limited upside potential amid execution challenges.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About DexCom, Inc.

Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.

Read more on DXCM

About Western Union Co

Western Union provides domestic and international money transfers through its global network of about 500,000 outside agents. It is the largest money transfer company in the world and one of only a few companies with a truly global agent network.

Read more on WU